Eli Lilly Revenue Jumps on Sales of Weight-Loss Drugs
Wall Street Journal
Sales of Mounjaro and Zepbound also led the drug maker to raise its full-year revenue and earnings guidance. Shares rose 7% premarket.
https://www.wsj.com/articles/eli-lilly-revenue-jumps-on-sales-of-weight-loss-drugs-73e2ffcb